Evaluate Performance of Callisto Eye vs. Wavetec AnalyzOR (CORTCO)

January 11, 2024 updated by: Maria C. Scott, Chesapeake Eyecare and Laser Center, LLC

Comparison of Operating Room Toric Placement Tools, CALLISTO Eye vs. Wavetec AnalyzOR (CORTCO)

The goal of this clinical trial is to evaluate two separate operating room cataract measuring tools in predicting the residual astigmatism (prediction error) in patients with corneal astigmatism.

The main question it aims to answer is:

Show the refractive predictability comparing the use of Operating Room cataract toric lens placement tools against the standard manual technique.

Participants will be implanted with the TECNIS Toric II IOL Lens Model ZCU; the second eye, if applicable, is to be implanted within 45 days of the first-eye surgery.

Researchers will compare two Operating Room cataract lens placement tools: the Zeiss CALLISTO vs. the Wavetec AnalyzOR to determine refractive predictability.

Study Overview

Status

Completed

Conditions

Detailed Description

To evaluate two separate operating room cataract measuring tools in predicting the residual astigmatism (prediction error) in patients with corneal astigmatism (maximum allowable up to 3.0D) comparing the ZEISS CALLISTO eye and the Wavetec AnalyzOR at the one-month post-operative visit. Both surgery rooms will be using Veracity, IOL Master and Zeiss Opmi Lumera i Operating Room Microscopes. Operating Room #1 will be utilizing the ZEISS CALLISTO eye for axis alignment, along with Veracity and IOL Master for lens selection, and Operating Room #2 will be utilizing the Wavetec AnalyzOR for lens selection and axis alignment. Procedure times for the ZEISS CALLISTO eye and the Wavetec AnalyzOR will be obtained by using a start/stop watch, including phakic power calculation and toric positioning. In addition, the suction on (start of LenSx), treatment time of LenSx in seconds, suction off (end of LenSx), start time of primary incision, the beginning of Phaco, end of phaco, CDE (Combined Diffused Energy) total and the end time of procedure will all be documented. All times will be analyzed and compared between Operating Room #1 and Operating Room #2.

Study Type

Observational

Enrollment (Actual)

36

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Maryland
      • Annapolis, Maryland, United States, 21401
        • Chesapeake Eye Care and Laser Center, LLC

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

Patients undergoing unilateral or bilateral cataract extraction

Description

Inclusion Criteria:

  • Unilateral or bilateral cataract extraction with single piece hydrophobic acrylic posterior capsular intraocular lens correcting astigmatism.
  • Clear intraocular media other than cataract.
  • Willing and able to complete all required postoperative visits.
  • Able to comprehend and sign a statement of informed consent in English.

Exclusion Criteria:

  • Ocular disease or pathology that, in the opinion of the Investigator, will affect the post-operative visual acuity and manifest refraction.
  • Prior intraocular or corneal refractive surgery, corneal transplant, or retinal detachment.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Group 1 (Operating Room #1) CALLISTO eye
Group 1 (Operating Room #1) will have preoperative measurements with the IOL Master 700 and lens selection will be based on Veracity. The subjects in group 1 will have LenSx surgery and placement of the lens will be based on the CALLISTO eye.
Cataract toric lens placement tool
Group 2 (Operating Room #2) Wavetec AnalyzOR
Group 2 (Operating Room #2) will also have preoperative measurements with the IOL Master700, but lens selection will be based on the Wavetec AnalyzOR. The subjects in group 2 will have LenSx surgery and placement of the lens will be based on the Wavetec AnalyzOR.
Cataract toric lens placement tool

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Diopters of Residual Cylinder
Time Frame: 1 Month postoperatively from implantation of intraocular lens
Diopters of Residual Cylinder at Month 1 with an upper boundary and lower boundary of +0.50 D and - 0.50 D
1 Month postoperatively from implantation of intraocular lens

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Accuracy of Residual Astigmatism (Predictive Error)
Time Frame: Month 1
Residual Astigmatism of +/- 0.25 D or less, +/- 0.75 D or less, +/- 1.00 or less
Month 1
Refractive predictability of the IOL (absolute difference between MRSE and target MRSE)
Time Frame: Month 1
MRSE within 0.25, 0.50, 0.75, 1.00 of target
Month 1
Uncorrected Distance Visual Acuities Achieved - Snellen
Time Frame: Month 1
Achievement of UCDVA of 20/20, 20/25, 20/30, 20/40 or better
Month 1
Procedure and Operating Room Time
Time Frame: Procedure time (up to 2 minutes)
Suction on (start of LenSx), treatment time of LenSx in seconds, Suction off (end of LenSx)
Procedure time (up to 2 minutes)
Operating Room Time
Time Frame: Operating Room Time (up to 30 minutes)
Start and end time of matching reference image to microscope image, start time-primary incision, beginning of Phaco, end of Phaco, CDE (Combined Diffused Energy) Total, Start and end time of phakic power calculation, start and end time of toric positioning, end time of procedure
Operating Room Time (up to 30 minutes)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Maria C. Scott, Chesapeake Eyecare and Laser Center, LLC

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 14, 2021

Primary Completion (Actual)

July 21, 2023

Study Completion (Actual)

July 21, 2023

Study Registration Dates

First Submitted

December 20, 2023

First Submitted That Met QC Criteria

January 11, 2024

First Posted (Actual)

January 22, 2024

Study Record Updates

Last Update Posted (Actual)

January 22, 2024

Last Update Submitted That Met QC Criteria

January 11, 2024

Last Verified

January 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • MCS12112021

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cataract

Clinical Trials on CALLISTO eye

3
Subscribe